PAPER Forni PE, Fornaro M, Guénette S, Wray S
SEARCH RESULTS
329963 RESULTS
PAPER Kirby J, Ning K, Ferraiuolo L, Heath PR, Ismail A, Kuo SW, Valori CF, Cox L, Sharrack B, Wharton SB, Ince PG, Shaw PJ, Azzouz M
Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis.
Brain. 2011 Feb;134(Pt 2):506-17. PubMed: 21228060PAPER Dowling P, Clynes M
Conditioned media from cell lines: a complementary model to clinical specimens for the discovery of disease-specific biomarkers.
Proteomics. 2011 Feb;11(4):794-804. PubMed: 21229588PAPER McQuown SC, Barrett RM, Matheos DP, Post RJ, Rogge GA, Alenghat T, Mullican SE, Jones S, Rusche JR, Lazar MA, Wood MA
HDAC3 is a critical negative regulator of long-term memory formation.
J Neurosci. 2011 Jan 12;31(2):764-74. PubMed: 21228185PAPER Kim DM, Ryu SW, Choi C
Long-term treatment of farnesyltransferase inhibitor FTI-277 induces neurotoxicity of hippocampal neurons from rat embryo in a ROS-dependent manner.
Biochem Biophys Res Commun. 2010 Dec 3;403(1):91-6. PubMed: 21040708PAPER Lee AM, Paulsson JF, Cruite J, Andaya AA, Trifilo MJ, Oldstone MB
Extraneural manifestations of prion infection in GPI-anchorless transgenic mice.
Virology. 2011 Mar 1;411(1):1-8. PubMed: 21227476PAPER Zhou D, Zhang M, Ye X, Gu C, Piser TM, Lanoue BA, Schock SA, Cheng YF, Grimm SW
In vitro metabolism of α7 neuronal nicotinic receptor agonist AZD0328 and enzyme identification for its N-oxide metabolite.
Xenobiotica. 2011 Mar;41(3):232-42. PubMed: 21226652PAPER Choi SH, Li Y
Elevated levels of BMP6 impair neurogenesis in Alzheimer's disease.
J Neurosci. 2011 Jan 12;31(2):371-2. PubMed: 21228148PAPER Krueger F, Pardini M, Huey ED, Raymont V, Solomon J, Lipsky RH, Hodgkinson CA, Goldman D, Grafman J
The role of the Met66 brain-derived neurotrophic factor allele in the recovery of executive functioning after combat-related traumatic brain injury.
J Neurosci. 2011 Jan 12;31(2):598-606. PubMed: 21228168PAPER Hefendehl JK, Wegenast-Braun BM, Liebig C, Eicke D, Milford D, Calhoun ME, Kohsaka S, Eichner M, Jucker M
Long-term in vivo imaging of β-amyloid plaque appearance and growth in a mouse model of cerebral β-amyloidosis.
J Neurosci. 2011 Jan 12;31(2):624-9. PubMed: 21228171PAPER Hongpaisan J, Sun MK, Alkon DL
PKC ε activation prevents synaptic loss, Aβ elevation, and cognitive deficits in Alzheimer's disease transgenic mice.
J Neurosci. 2011 Jan 12;31(2):630-43. PubMed: 21228172PAPER Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F, Wu T, Hamto P, Devidze N, Yu GQ, Palop JJ, Noebels JL, Mucke L
Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease.
J Neurosci. 2011 Jan 12;31(2):700-11. PubMed: 21228179PAPER Breitner JC
Apolipoprotein e, Alzheimer's disease, and amyloid: do we have the cart before the horse?
J Alzheimers Dis. 2011;23(1):171-2. PubMed: 21228459PAPER
Upcoming meetings related to Alzheimer's disease.
Rev Neurol. 2011 Jan 16;52(2):101-111. PubMed: 21228460PAPER Hori K, Konishi K, Watanabe K, Uchida H, Tsuboi T, Moriyasu M, Tominaga I, Hachisu M
Influence of anticholinergic activity in serum on clinical symptoms of Alzheimer's disease.
Neuropsychobiology. 2011;63(3):147-53. PubMed: 21228606Current Filters
No filters selected